logo
logo

Affinia Therapeutics Appoints Rami Daoud As Chief Business and Financial Officer

Sep 11, 2024•11 months ago

Position

Chief Financial Officer

Company

Affinia Therapeutics

Rami Daoud
WalthamTherapeuticsBiotechnologyHealth Care

Description

Affinia Therapeutics announced the appointment of Rami Daoud, M.B.A., as Chief Business and Financial Officer. Rami brings a successful track record in business development and biotech finance and corporate strategy, with expertise across various therapeutic areas and commercialization models.

Company Information

Company

Affinia Therapeutics

Location

Waltham, Massachusetts, United States

About

Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases. Affinia Therapeutics’ pipeline of first-in-class or best-in-class product candidates in cardiovascular and neurological diseases leverages its proprietary next-generation capsids, payloads, or manufacturing approaches and have shown efficacy, safety, and differentiation in relevant animal models.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months